Correlation Between Abcellera Biologics and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Abcellera Biologics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and Acumen Pharmaceuticals.
Diversification Opportunities for Abcellera Biologics and Acumen Pharmaceuticals
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Abcellera and Acumen is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Abcellera Biologics and Acumen Pharmaceuticals
Given the investment horizon of 90 days Abcellera Biologics is expected to generate 0.87 times more return on investment than Acumen Pharmaceuticals. However, Abcellera Biologics is 1.15 times less risky than Acumen Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 268.00 in Abcellera Biologics on September 14, 2024 and sell it today you would earn a total of 27.00 from holding Abcellera Biologics or generate 10.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Abcellera Biologics vs. Acumen Pharmaceuticals
Performance |
Timeline |
Abcellera Biologics |
Acumen Pharmaceuticals |
Abcellera Biologics and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abcellera Biologics and Acumen Pharmaceuticals
The main advantage of trading using opposite Abcellera Biologics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Acumen Pharmaceuticals vs. Puma Biotechnology | Acumen Pharmaceuticals vs. Iovance Biotherapeutics | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |